182 related articles for article (PubMed ID: 25521200)
1. Network-based biomarkers enhance classical approaches to prognostic gene expression signatures.
Barter RL; Schramm SJ; Mann GJ; Yang YH
BMC Syst Biol; 2014; 8 Suppl 4(Suppl 4):S5. PubMed ID: 25521200
[TBL] [Abstract][Full Text] [Related]
2. AID/APOBEC-network reconstruction identifies pathways associated with survival in ovarian cancer.
Svoboda M; Meshcheryakova A; Heinze G; Jaritz M; Pils D; Castillo-Tong DC; Hager G; Thalhammer T; Jensen-Jarolim E; Birner P; Braicu I; Sehouli J; Lambrechts S; Vergote I; Mahner S; Zimmermann P; Zeillinger R; Mechtcheriakova D
BMC Genomics; 2016 Aug; 17(1):643. PubMed ID: 27527602
[TBL] [Abstract][Full Text] [Related]
3. Development and Validation of an Immune-Related Prognostic Signature for Ovarian Cancer Based on Weighted Gene Coexpression Network Analysis.
An Y; Yang Q
Biomed Res Int; 2020; 2020():7594098. PubMed ID: 33381581
[TBL] [Abstract][Full Text] [Related]
4. In-Silico Evaluation of Genetic Alterations in Ovarian Carcinoma and Therapeutic Efficacy of NSC777201, as a Novel Multi-Target Agent for TTK, NEK2, and CDK1.
Khedkar HN; Wang YC; Yadav VK; Srivastava P; Lawal B; Mokgautsi N; Sumitra MR; Wu ATH; Huang HS
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072728
[TBL] [Abstract][Full Text] [Related]
5. CAERUS: predicting CAncER oUtcomeS using relationship between protein structural information, protein networks, gene expression data, and mutation data.
Zhang KX; Ouellette BF
PLoS Comput Biol; 2011 Mar; 7(3):e1001114. PubMed ID: 21483478
[TBL] [Abstract][Full Text] [Related]
6. A critical evaluation of network and pathway-based classifiers for outcome prediction in breast cancer.
Staiger C; Cadot S; Kooter R; Dittrich M; Müller T; Klau GW; Wessels LF
PLoS One; 2012; 7(4):e34796. PubMed ID: 22558100
[TBL] [Abstract][Full Text] [Related]
7. A novel risk score system for assessment of ovarian cancer based on co-expression network analysis and expression level of five lncRNAs.
Zhao Q; Fan C
BMC Med Genet; 2019 Jun; 20(1):103. PubMed ID: 31182053
[TBL] [Abstract][Full Text] [Related]
8. A network-pathway based module identification for predicting the prognosis of ovarian cancer patients.
Wang X; Wang SS; Zhou L; Yu L; Zhang LM
J Ovarian Res; 2016 Nov; 9(1):73. PubMed ID: 27806724
[TBL] [Abstract][Full Text] [Related]
9. Identifying prognostic signature in ovarian cancer using DirGenerank.
Wang JY; Chen LL; Zhou XH
Oncotarget; 2017 Jul; 8(28):46398-46413. PubMed ID: 28615526
[TBL] [Abstract][Full Text] [Related]
10. Biomarker robustness reveals the PDGF network as driving disease outcome in ovarian cancer patients in multiple studies.
Ben-Hamo R; Efroni S
BMC Syst Biol; 2012 Jan; 6():3. PubMed ID: 22236809
[TBL] [Abstract][Full Text] [Related]
11. VAN: an R package for identifying biologically perturbed networks via differential variability analysis.
Jayaswal V; Schramm SJ; Mann GJ; Wilkins MR; Yang YH
BMC Res Notes; 2013 Oct; 6():430. PubMed ID: 24156242
[TBL] [Abstract][Full Text] [Related]
12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
13. Incorporating topological information for predicting robust cancer subnetwork markers in human protein-protein interaction network.
Khunlertgit N; Yoon BJ
BMC Bioinformatics; 2016 Oct; 17(Suppl 13):351. PubMed ID: 27766944
[TBL] [Abstract][Full Text] [Related]
14. Identification of a histone family gene signature for predicting the prognosis of cervical cancer patients.
Li X; Tian R; Gao H; Yang Y; Williams BRG; Gantier MP; McMillan NAJ; Xu D; Hu Y; Gao Y
Sci Rep; 2017 Nov; 7(1):16495. PubMed ID: 29184082
[TBL] [Abstract][Full Text] [Related]
15. Identification and validation of core genes in tumor-educated platelets for human gastrointestinal tumor diagnosis using network-based transcriptomic analysis.
Jiang Y; He J; Wang X; Liu C; Zhou W; Liu D; Guo Z; Liu K
Platelets; 2023 Dec; 34(1):2212071. PubMed ID: 37212262
[TBL] [Abstract][Full Text] [Related]
16. Systematic module approach identifies altered genes and pathways in four types of ovarian cancer.
Liu J; Wang HL; Ma FM; Guo HP; Fang NN; Wang SS; Li XH
Mol Med Rep; 2017 Dec; 16(6):7907-7914. PubMed ID: 28983627
[TBL] [Abstract][Full Text] [Related]
17. BMRF-MI: integrative identification of protein interaction network by modeling the gene dependency.
Shi X; Wang X; Shajahan A; Hilakivi-Clarke L; Clarke R; Xuan J
BMC Genomics; 2015; 16 Suppl 7(Suppl 7):S10. PubMed ID: 26099273
[TBL] [Abstract][Full Text] [Related]
18. Identifying cancer biomarkers by network-constrained support vector machines.
Chen L; Xuan J; Riggins RB; Clarke R; Wang Y
BMC Syst Biol; 2011 Oct; 5():161. PubMed ID: 21992556
[TBL] [Abstract][Full Text] [Related]
19. Network based consensus gene signatures for biomarker discovery in breast cancer.
Fröhlich H
PLoS One; 2011; 6(10):e25364. PubMed ID: 22046239
[TBL] [Abstract][Full Text] [Related]
20. A network module-based method for identifying cancer prognostic signatures.
Wu G; Stein L
Genome Biol; 2012 Dec; 13(12):R112. PubMed ID: 23228031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
